Ridge-i Inc. (5572.T)
JPY 2552.0
(-1.09%)
JPY 2552.0
(-1.09%)
| Breakdown | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 1.07 Billion | 790.38 Million | 968.52 Million | 419.44 Million |
| Cost of Revenue | 336.34 Million | 274.73 Million | 355.94 Million | 227.96 Million |
| Gross Profit | 735.61 Million | 515.64 Million | 612.57 Million | 191.48 Million |
| Operating Expenses | 582.87 Million | 445.3 Million | 556.17 Million | 348.04 Million |
| Selling, General and Administrative Expenses | - | 392 Million | 556.17 Million | 348.04 Million |
| Research and Development Expenses | - | 52 Million | 68 Million | 11 Million |
| Other Expenses | 582.87 Million | -9.54 Million | 53.08 Million | 9.15 Million |
| Cost and Expenses | 919.21 Million | 720.03 Million | 912.11 Million | 576 Million |
| Operating Income | 152.73 Million | 70.34 Million | 56.4 Million | -156.56 Million |
| Interest Expense | - | - | - | - |
| Income Tax Expense | 31.31 Million | 16.33 Million | -40.56 Million | 1.36 Million |
| Earnings before Tax | 153.01 Million | 60.89 Million | 109.5 Million | -147.4 Million |
| Net Income | 121.69 Million | 44.56 Million | 150.06 Million | -148.76 Million |
| Earnings Per Share Basic | 31.97 | 12.54 | 43.32 | -42.94 |
| Earnings Per Share Diluted | 30.52 | 11.80 | 39.55 | -39.21 |
| Weighted Average Shares Outstanding | 3.8 Million | 3.55 Million | 3.46 Million | 3.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.98 Million | 3.55 Million | 3.79 Million | 3.79 Million |
| Gross Margin | 0.69 | 0.65 | 0.63 | 0.46 |
| EBIT Margin | 0.16 | 0.11 | 0.09 | -0.29 |
| Profit Margin | 0.11 | 0.06 | 0.15 | -0.35 |
| EBITDA | 171.76 Million | 74.51 Million | 141.54 Million | -123.39 Million |
| Earnings Before Tax Margin | 0.14 | 0.09 | 0.06 | -0.37 |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 291.61 Million | 288.73 Million | 279.09 Million | 212.51 Million | 790.38 Million | 163.27 Million |
| Cost of Revenue | 96 Million | 70.1 Million | 93.09 Million | 75.37 Million | 274.73 Million | 36.63 Million |
| Gross Profit | 195.61 Million | 218.62 Million | 186 Million | 137.13 Million | 515.64 Million | 126.64 Million |
| Operating Expenses | 172.64 Million | 137.33 Million | 142.55 Million | 132.08 Million | 445.3 Million | 154.42 Million |
| Selling, General and Administrative Expenses | 172.64 Million | 137 Million | 142 Million | 132 Million | - | 102 Million |
| Research and Development Expenses | 12.35 Million | 7.28 Million | 9.11 Million | 18.53 Million | - | 52 Million |
| Other Expenses | - | 111 Thousand | - | - | -9.54 Million | -171 Thousand |
| Cost and Expenses | 268.65 Million | 207.44 Million | 235.65 Million | 207.46 Million | 720.03 Million | 191.05 Million |
| Operating Income | 22.96 Million | 81.28 Million | 43.44 Million | 5.04 Million | 70.34 Million | -27.77 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -12.95 Million | 28.52 Million | 13.75 Million | 2 Million | 16.33 Million | -7.75 Million |
| Earnings before Tax | 22.97 Million | 81.4 Million | 43.57 Million | 5.05 Million | 60.89 Million | -27.86 Million |
| Net Income | 35.93 Million | 52.88 Million | 29.82 Million | 3.05 Million | 44.56 Million | -20.11 Million |
| Earnings Per Share Basic | 9.37 | 13.97 | 7.64 | 0.80 | - | -5.30 |
| Earnings Per Share Diluted | 9.37 | 12.89 | 7.64 | 0.76 | - | -5.30 |
| Weighted Average Shares Outstanding | 3.83 Million | 4.11 Million | 3.79 Million | 3.79 Million | 3.55 Million | 3.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.83 Million | 4.11 Million | 3.79 Million | 4.01 Million | 3.55 Million | 3.79 Million |
| Gross Margin | 0.67 | 0.76 | 0.67 | 0.65 | 0.65 | 0.78 |
| EBIT Margin | 0.10 | 0.28 | 0.16 | 0.02 | - | -0.17 |
| Profit Margin | 0.12 | 0.18 | 0.11 | 0.01 | 0.06 | -0.12 |
| EBITDA | 29.03 Million | 81.28 Million | 43.44 Million | 5.04 Million | - | -27.77 Million |
| Earnings Before Tax Margin | 0.08 | 0.28 | 0.16 | 0.02 | 0.09 | -0.17 |
300198
DOCN
603709
9878
1260
AMRX